Amgen Financial Statements
Amgen Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Amgen Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 15,003.0 | 14,771.0 | 14,268.0 |
| Gross Profit ($ mil.) | 12,707.0 | 12,223.0 | 12,173.0 |
| Operating Income ($ mil.) | 5,566.0 | 4,289.0 | 4,149.0 |
| Total Net Income ($ mil.) | 4,196.0 | 3,166.0 | 2,950.0 |
| Diluted EPS (Net Income) | 3.90 | 2.82 | 2.48 |
Amgen Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Mar 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,812.0 | 3,713.0 | 3,308.0 |
| Gross Profit ($ mil.) | 3,267.0 | 3,182.0 | 2,831.0 |
| Operating Income ($ mil.) | 1,679.0 | 1,507.0 | -- |
| Total Net Income ($ mil.) | 1,386.0 | 1,269.0 | 1,019.0 |
| Diluted EPS (Net Income) | 1.36 | 1.25 | 0.98 |
Amgen Stock Quote & Chart
11/06/09 16:00:01 EST •
NASDAQ •
54.69
•
 +0.6400
•
+1.1841 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Amgen Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.86 | 7.49 | 7.00 |
| Price/Earnings Ratio | 12.63 | 92.59 | 25.45 |
| Price/Book Ratio | 2.40 | 3.46 | 6.74 |
| Price/Cash Flow Ratio | 10.62 | 41.15 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Amgen Financial Ratios
Amgen Competitive Intelligence
| Johnson & Johnson | Novartis | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 63,747.0 | 42,584.0 | 40,057.0 |
| Employees | 118,700 | 96,717 | 98,213 |
| Market Cap ($ mil.) | 165,490.8 | 119,419.7 | 97,482.8 |
Competitive Landscape
